Infant Electrode Belt
by Sentry Medical Products, Inc.
510(k) K830362
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK830362 | Date3 Jun 1983 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DRX
- Device Class
- Class II
- Regulation
- 21 CFR Part 870.2360
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 25 Sep 2026
An infant electrode belt is a device used to secure electrodes to an infant for monitoring purposes. It is designed to hold electrodes in place during cardiovascular monitoring procedures.
The device is supplied non-sterile and is intended for single use. It is used in clinical settings for infant patients and has received FDA 510(k) clearance under product code DRX, with a traditional clearance type and cardiovascular advisory committee review.
Other devices from Sentry Medical Products, Inc.
Questions
AI-generated answers, 25 Sep 2026
What is the infant electrode belt used for?
The infant electrode belt is used to secure electrodes to an infant during cardiovascular monitoring procedures, holding them in place to ensure reliable signal acquisition while minimizing movement artifacts in clinical settings.
Is the infant electrode belt sterile or non-sterile, and is it reusable?
The device is supplied non-sterile and is intended for single use only; it should not be cleaned, resterilized, or reused due to potential degradation of material integrity and risk of cross-contamination after initial application.
What regulatory pathway was used for the infant electrode belt, and what is its product code?
The infant electrode belt received FDA 510(k) clearance under product code DRX, with a traditional clearance type and review by the cardiovascular advisory committee, indicating it was found substantially equivalent to a legally marketed predicate device.